141 related articles for article (PubMed ID: 11027080)
1. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
[TBL] [Abstract][Full Text] [Related]
2. Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.
Lurie G; Thompson P; McDuffie KE; Carney ME; Terada KY; Goodman MT
Obstet Gynecol; 2007 Mar; 109(3):597-607. PubMed ID: 17329510
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the association of oral contraceptives and ovarian cancer.
Cramer DW; Hutchison GB; Welch WR; Scully RE; Knapp RC
N Engl J Med; 1982 Oct; 307(17):1047-51. PubMed ID: 7121514
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
8. Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Int J Epidemiol; 1989 Sep; 18(3):538-45. PubMed ID: 2807655
[TBL] [Abstract][Full Text] [Related]
9. Short-term oral contraceptive use and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Am J Epidemiol; 2005 Jul; 162(1):66-72. PubMed ID: 15961588
[TBL] [Abstract][Full Text] [Related]
10. Stroke in users of low-dose oral contraceptives.
Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medication use and risk of epithelial ovarian cancer.
Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
[TBL] [Abstract][Full Text] [Related]
12. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
13. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
[TBL] [Abstract][Full Text] [Related]
14. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
Gross TP; Schlesselman JJ
Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
[TBL] [Abstract][Full Text] [Related]
15. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
16. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
17. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
18. Estrogen replacement therapy and risk of epithelial ovarian cancer.
Risch HA
Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
[TBL] [Abstract][Full Text] [Related]
19. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
20. Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls.
Morabia A; Szklo M; Stewart W; Schuman L; Thomas DB
Prev Med; 1993 Mar; 22(2):178-86. PubMed ID: 8483857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
